Octagon Capital Advisors LP Quant / Systematic

Location: New York, NY

CIK: 0001839435 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value: $514M (100.0% shares, 0.0% debt)

Holdings (28)

APLS APELLIS PHARMACEUTICALS INC 18.6%

Value $95.55M Shares 2,020,911 Est. Cost $47.28 Unrealized -16.7%

RCUS ARCUS BIOSCIENCES INC 16.5%

Value $84.79M Shares 2,095,231 Est. Cost $33.98 Unrealized +14.1%

Value $49.74M Shares 1,049,691 Est. Cost $59.03 Unrealized —

FDMT 4D MOLECULAR THERAPEUTICS IN 6.6%

Value $34.03M Shares 1,551,070 Est. Cost $30.38 Unrealized -19.3%

BBIO BRIDGEBIO PHARMA INC 5.7%

Value $29.48M Shares 1,767,486 Est. Cost $46.70 Unrealized -9.4%

CLDX CELLDEX THERAPEUTICS INC NEW 5.7%

Value $29.42M Shares 761,398 Est. Cost $25.60 Unrealized +70.3%

— ITEOS THERAPEUTICS INC 4.1%

Value $20.99M Shares 450,776 Est. Cost $46.56 Unrealized —

KROS KEROS THERAPEUTICS INC 3.9%

Value $19.91M Shares 340,214 Est. Cost $49.87 Unrealized 0.0%

STOK STOKE THERAPEUTICS INC 3.7%

Value $18.8M Shares 783,769 Est. Cost $28.21 Unrealized -15.4%

VERA VERA THERAPEUTICS INC 3.5%

Value $17.93M Shares 670,940 Est. Cost $15.54 Unrealized +42.3%

GOSS GOSSAMER BIO INC 3.3%

Value $17.11M Shares 1,513,138 Est. Cost $9.81 Unrealized +21.1%

ARVN ARVINAS INC 2.9%

Value $14.66M Shares 178,500 Est. Cost $37.11 Unrealized +119.3%

IPSC CENTURY THERAPEUTICS INC 2.2%

Value $11.14M Shares 702,623 Est. Cost $24.92 Unrealized -24.6%

RNAM AVIDITY BIOSCIENCES INC 2.1%

Value $10.62M Shares 446,641 Est. Cost $28.99 Unrealized -17.6%

— CHINOOK THERAPEUTICS INC 1.6%

Value $8.155M Shares 500,000 Est. Cost $16.31 Unrealized —

— PROMETHEUS BIOSCIENCES INC 1.5%

Value $7.908M Shares 200,000 Est. Cost $18.26 Unrealized —

DYN DYNE THERAPEUTICS INC 1.4%

Value $6.94M Shares 583,649 Est. Cost $19.71 Unrealized -28.7%

CTKB CYTEK BIOSCIENCES INC 1.3%

Value $6.528M Shares 400,000 Est. Cost $23.52 Unrealized -11.0%

CRDF CARDIFF ONCOLOGY INC 1.1%

Value $5.906M Shares 982,753 Est. Cost $14.50 Unrealized -58.9%

IMVT IMMUNOVANT INC 0.9%

Value $4.881M Shares 572,862 Est. Cost $8.26 Unrealized 0.0%

MLTX HELIX ACQUISITION CORP 0.8%

Value $3.956M Shares 400,000 Est. Cost $11.37 Unrealized —

GLUE MONTE ROSA THERAPEUTICS INC 0.6%

Value $3.063M Shares 150,000 Est. Cost $20.37 Unrealized +2.8%

— AMBRX BIOPHARMA INC 0.6%

Value $3.042M Shares 336,868 Est. Cost $19.60 Unrealized —

— JIYA ACQUISITION CORP 0.6%

Value $2.931M Shares 300,000 Est. Cost $10.30 Unrealized —

OLMA OLEMA PHARMACEUTICALS INC 0.4%

Value $2.166M Shares 231,417 Est. Cost $20.72 Unrealized 0.0%

— OMEGA THERAPEUTICS INC 0.4%

Value $1.999M Shares 176,470 Est. Cost $18.85 Unrealized —

— CONNECT BIOPHARMA HLDGS LTD 0.3%

Value $1.442M Shares 279,921 Est. Cost $18.50 Unrealized —

CMPX COMPASS THERAPEUTICS INC 0.1%

Value $761K Shares 240,000 Est. Cost $3.29 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
APLS	APELLIS PHARMACEUTICALS INC	2,020,911	$95.55M	18.6%	$47.28	-16.7%	COM	03753U106
RCUS	ARCUS BIOSCIENCES INC	2,095,231	$84.79M	16.5%	$33.98	+14.1%	COM	03969F109
NBP	I MAB	1,049,691	$49.74M	9.7%	$59.03	—	SPONSORED ADS	44975P103
FDMT	4D MOLECULAR THERAPEUTICS IN	1,551,070	$34.03M	6.6%	$30.38	-19.3%	COM	35104E100
BBIO	BRIDGEBIO PHARMA INC	1,767,486	$29.48M	5.7%	$46.70	-9.4%	COM	10806X102
CLDX	CELLDEX THERAPEUTICS INC NEW	761,398	$29.42M	5.7%	$25.60	+70.3%	COM NEW	15117B202
—	ITEOS THERAPEUTICS INC	450,776	$20.99M	4.1%	$46.56	—	COM	46565G104
KROS	KEROS THERAPEUTICS INC	340,214	$19.91M	3.9%	$49.87	0.0%	COM	492327101
STOK	STOKE THERAPEUTICS INC	783,769	$18.8M	3.7%	$28.21	-15.4%	COM	86150R107
VERA	VERA THERAPEUTICS INC	670,940	$17.93M	3.5%	$15.54	+42.3%	CL A	92337R101
GOSS	GOSSAMER BIO INC	1,513,138	$17.11M	3.3%	$9.81	+21.1%	COM	38341P102
ARVN	ARVINAS INC	178,500	$14.66M	2.9%	$37.11	+119.3%	COM	04335A105
IPSC	CENTURY THERAPEUTICS INC	702,623	$11.14M	2.2%	$24.92	-24.6%	COM	15673T100
RNAM	AVIDITY BIOSCIENCES INC	446,641	$10.62M	2.1%	$28.99	-17.6%	COM	05370A108
—	CHINOOK THERAPEUTICS INC	500,000	$8.155M	1.6%	$16.31	—	COM	16961L106
—	PROMETHEUS BIOSCIENCES INC	200,000	$7.908M	1.5%	$18.26	—	COM	74349U108
DYN	DYNE THERAPEUTICS INC	583,649	$6.94M	1.4%	$19.71	-28.7%	COM	26818M108
CTKB	CYTEK BIOSCIENCES INC	400,000	$6.528M	1.3%	$23.52	-11.0%	COM	23285D109
CRDF	CARDIFF ONCOLOGY INC	982,753	$5.906M	1.1%	$14.50	-58.9%	COM	14147L108
IMVT	IMMUNOVANT INC	572,862	$4.881M	0.9%	$8.26	0.0%	COM	45258J102
MLTX	HELIX ACQUISITION CORP	400,000	$3.956M	0.8%	$11.37	—	COM CL A	G4444C102
GLUE	MONTE ROSA THERAPEUTICS INC	150,000	$3.063M	0.6%	$20.37	+2.8%	COM	61225M102
—	AMBRX BIOPHARMA INC	336,868	$3.042M	0.6%	$19.60	—	SPONSORED ADS	02290A102
—	JIYA ACQUISITION CORP	300,000	$2.931M	0.6%	$10.30	—	COM CL A	47760M102
OLMA	OLEMA PHARMACEUTICALS INC	231,417	$2.166M	0.4%	$20.72	0.0%	COM	68062P106
—	OMEGA THERAPEUTICS INC	176,470	$1.999M	0.4%	$18.85	—	COMMON STOCK	68217N105
—	CONNECT BIOPHARMA HLDGS LTD	279,921	$1.442M	0.3%	$18.50	—	ADS	207523101
CMPX	COMPASS THERAPEUTICS INC	240,000	$761K	0.1%	$3.29	0.0%	COM	20454B104